Position in ETON
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,209,734
+$1,583,955 QoQ
Shares Held
116,291
+9.3% QoQ
Ownership
0.407%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 163 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ETON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. ETON ranks #20 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
2,076,260 | $349,932,860 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,775,349 | $67,753,490 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,184,378 | $55,085,420 | |
| 4 | ALKS |
Alkermes plc.
|
1,038,311 | $54,407,496 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
561,480 | $35,906,646 | |
| 6 | ZTS |
Zoetis Inc.
|
386,428 | $27,768,716 | |
| 7 | LQDA |
Liquidia Corp
|
266,829 | $21,274,276 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,556,089 | $19,181,134 |
All Filings in ETON
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,209,734 | 116,291 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,625,779 | 106,393 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,295,339 | 76,602 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,223,928 | 286,421 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,057,366 | 214,552 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,068,967 | 82,355 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,497,940 | 112,458 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $54,235 | 16,485 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $119,212 | 31,790 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $229,950 | 52,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $331,731 | 79,552 | Shares | Sole | 2023-11-14 | |
| 2021-09-30 | $91,072 | 18,070 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $1,024,719 | 139,989 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,028,363 | 126,490 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||